Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENT OF CASH FLOWS

v3.21.2
CONDENSED STATEMENT OF CASH FLOWS - USD ($)
 3 Months Ended 8 Months Ended
Sep. 30, 2021
Sep. 30, 2021
Cash Flows from Operating Activities:    
Net loss $ (1,077,312) $ (1,086,499)
Adjustments to reconcile net loss to net cash used in operating activities:    
Formation cost paid by Sponsor in exchange for issuance of Founder Shares   5,000
Transaction costs allocated to warrants associated with the Initial Public Offering 373,194 373,194
Change in the fair value of warrant liability 673,667 673,667
Changes in operating assets and liabilities:    
Prepaid expenses   (627,088)
Accrued expenses   6,965
Net cash used in operating activities   (654,761)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account   (236,900,000)
Net cash used in investing activities   (236,900,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid   225,400,000
Proceeds from sale of Private Placement Warrants   14,500,000
Proceeds from promissory note – related party   132,446
Payment of offering costs   (739,341)
Net cash provided by financing activities   239,293,105
Net Change in Cash   1,738,344
Cash – End of period 1,738,344 1,738,344
Non-Cash investing and financing activities:    
Offering costs included in accrued offering costs   3,598
Offering costs paid by Sponsor in exchange for issuance of Founder Shares   20,000
Initial classification of ordinary share subject to possible redemption   236,900,000
Deferred Underwriting Fee Payable $ 8,050,000 $ 8,050,000